Bank of Maharashtra (MAHABANK) Q1 FY27 Results: Analysis, Positives, Concerns & Outlook
Bank of Maharashtra's Q1 FY27 numbers came in strong, with revenue of Rs. 9,063.29 Cr (+15.03% YoY) and PAT growth of +26.84% YoY. Here's a quick read of what worked, what to watch, and what management said.
| Results date | July 10, 2026 |
|---|---|
| Quarter | Q1 FY 2026-2027 |
| Revenue (Q1) | Rs. 9,063.29 Cr (+15.03% YoY) |
| PAT (Q1) | Rs. 2,020.19 Cr (+26.84% YoY) |
| EBITDA margin | 34.39% (+177 bps YoY) |
| EPS (Q1) | Rs. 2.63 (+27.05% YoY) |
| Market cap | Rs. 64,362.95 Cr |
| CMP | Rs. 83.68 |
Quarter Snapshot
MAHABANK delivered a strong Q1 with advances growth of 27.2% YoY and PPOP growth of 21.3% YoY, beating FY27 guidance on multiple metrics. However, CASA ratio declined to 49% and deposit growth lagged, while a one-time COVID provision reversal boosted reported PAT. The bank's asset quality remains pristine and capital adequacy is robust, but farm loan waiver risks and funding mix deterioration are watch items.
Key Investment Insights
Key Positives
- Advances grew 27.2% YoY, well above the 18% FY27 guidance.
- PPOP grew 21.3% YoY to Rs.3,117.17 Cr.
- Cost-to-income improved to 35.04% from 37.57% a year ago.
- ROA (annualized) at 1.90% exceeded the 1.80% full-year target.
- Non-interest income grew 24.7% YoY, above the 10% guidance.
- GNPA stable at 1.45% and NNPA at 0.13%.
- CRAR improved to 18.64% with CET1 at 15.56%.
Risk Factors
- CASA ratio declined to 49% from 52.51% in Q4FY26, a 350 bps QoQ drop.
- Deposit growth at 12.9% YoY lagged advances growth, leading to borrowings up 63% YoY.
- Treasury PBT fell 13.6% YoY due to MTM losses.
- Farm loan waiver impact in Maharashtra not yet provisioned; expected from Q2FY27.
- Reported PAT was boosted by a Rs.250 Cr one-time COVID provision reversal.
Ask about this
Ask Cofacto a question about this result. Answers cite filings and company data.
Related
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.